Excess adiposity and survival in patients with colorectal cancer: A systematic review

Obesity Reviews

Volumn 15, Issue 5, 2014, Pages 434-451

  Parkin, Edward ^a,b   O'Reilly, Derek A ^b   Sherlock, David J ^b   Manoharan, Prakash ^a,c   Renehan, Andrew G ^a,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Body mass index; Cancer related mortality; Colorectal cancer; Survival

Indexed keywords

BODY MASS; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; FACTUAL DATABASE; FEMALE; HUMAN; INCIDENCE; MALE; META ANALYSIS (TOPIC); OBESITY; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

ADIPOSITY; BODY MASS INDEX; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INCIDENCE; MALE; META-ANALYSIS AS TOPIC; OBESITY; OBSERVATIONAL STUDY AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84899108371     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12140     Document Type: Article

References (74)

1. Wormser D, Kaptoge S, Di Angelantonio E etal. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 2011; 377: 1085-1095.
2. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev 2007; 29: 115-128.
3. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
4. Lim SS, Vos T, Flaxman AD etal. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.
5. Finucane MM, Stevens GA, Cowan MJ etal. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557-567.
6. Sperrin M, Marshall AD, Higgins V, Buchan IE, Renehan AG. Slowing down of adult body mass index trend increases in England: a latent class analysis of cross-sectional surveys (1992-2010). Int J Obes (Lond) 2013; 15 October 2013; doi: 10.1038/ijo.2013.161.
7. Renehan AG, Soerjomataram I, Tyson M etal. Incident cancer burden attributable to excess body mass index in 30 European countries. Int J Cancer 2010; 126: 692-702.
8. Harriss DJ, Atkinson G, George K etal. Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 2009; 11: 547-563.
9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
10. World Cancer Reserach Fund (WCRF). Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, 2nd edn. American Institute for Cancer Research: Washington, DC, 2007.
11. Demark-Wahnefried W, Platz EA, Ligibel JA etal. The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomarkers Prev 2012; 21: 1244-1259.
12. Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis. Breast Cancer Res Treat 2012; 134: 769-781.
13. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010; 123: 627-635.
14. Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res (Phila) 2011; 4: 486-501.
15. Renehan AG, Egger M, Zwahlen M Body mass index and cancer risk: the evidence for causal association. BMC Open Journal of Obesity [10.2174/1876823701002020012], 2010.
16. Birks S, Peeters A, Backholer K, O'Brien P, Brown W. A systematic review of the impact of weight loss on cancer incidence and mortality. Obes Rev 2012; 13: 868-891.
17. Roberts DL, Dive C, Renehan AG. Biological mechanisms linking obesity and cancer risk: new perspectives. Annu Rev Med 2010; 61: 301-316.
18. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007; 32: 4-12.
19. Primeau V, Coderre L, Karelis AD etal. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011; 35: 971-981.
20. Huxley R, Mendis S, Zheleznyakov E, Reddy S, Chan J. Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk - a review of the literature. Eur J Clin Nutr 2010; 64: 16-22.
21. Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut 2013; 62: 933-947.
22. Ma Y, Yang Y, Wang F etal. Obesity and risk of colorectal cancer: a systematic review of prospective studies. PLoS ONE 2013; 8: e53916.
23. Pischon T, Lahmann PH, Boeing H etal. Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-931.
24. Keimling M, Renehan AG, Behrens G etal. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemiol Biomarkers Prev 2013; 22: 1383-1394.
25. Yoshizumi T, Nakamura T, Yamane M etal. Abdominal fat: standardized technique for measurement at CT. Radiology 1999; 211: 283-286.
26. Pou KM, Massaro JM, Hoffmann U etal. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care 2009; 32: 481-485.
27. Fox CS, Massaro JM, Hoffmann U etal. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48.
28. Renehan AG, Yeh HC, Johnson JA, Wild SH, Gale EA, Moller H. Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer. Diabetologia 2012; 55: 1619-1632.
29. Punt CJ, Buyse M, Kohne CH etal. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst 2007; 99: 998-1003.
30. Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration. PLoS Med 2012; 9: e1001216.
31. Crosbie EJ, Roberts C, Qian W, Swart AM, Kitchener HC, Renehan AG. Body mass index does not influence post-treatment survival in early stage endometrial cancer: results from the MRC ASTEC trial. Eur J Cancer 2012; 48: 853-864.
32. Vandenbroucke JP, von Elm E, Altman DG etal. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007; 147: W163-W194.
33. Whiting PF, Rutjes AW, Westwood ME etal. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529-536.
34. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19: 3119-3130.
35. Colangelo LA, Gapstur SM, Gann PH, Dyer AR, Liu K. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11: 385-391.
36. Haydon AM, Macinnis RJ, English DR, Giles GG. Effect of physical activity and body size on survival after diagnosis with colorectal cancer. Gut 2006; 55: 62-67.
37. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134-1145.
38. Tamakoshi K, Wakai K, Kojima M etal. A prospective study of body size and colon cancer mortality in Japan: the JACC study. Int J Obes Relat Metab Disord 2004; 28: 551-558.
39. Campbell PT, Newton CC, Dehal AN, Jacobs EJ, Patel AV, Gapstur SM. Impact of body mass index on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. J Clin Oncol 2012; 30: 42-52.
40. Doria-Rose VP, Newcomb PA, Morimoto LM, Hampton JM, Trentham-Dietz A. Body mass index and the risk of death following the diagnosis of colorectal cancer in postmenopausal women (United States). Cancer Causes Control 2006; 17: 63-70.
41. Kuiper JG, Phipps AI, Neuhouser ML etal. Recreational physical activity, body mass index, and survival in women with colorectal cancer. Cancer Causes Control 2012; 23: 1939-1948.
42. Park SM, Lim MK, Jung KW etal. Prediagnosis smoking, obesity, insulin resistance, and second primary cancer risk in male cancer survivors: National Health Insurance Corporation Study. J Clin Oncol 2007; 25: 4835-4843.
43. Prizment AE, Flood A, Anderson KE, Folsom AR. Survival of women with colon cancer in relation to precancer anthropometric characteristics: the Iowa Women's Health Study. Cancer Epidemiol Biomarkers Prev 2010; 19: 2229-2237.
44. Alipour S, Kennecke HF, Woods R etal. Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer. J Gastrointest Cancer 2012; 44: 203-210.
45. Asghari-Jafarabadi M, Hajizadeh E, Kazemnejad A, Fatemi SR. Site-specific evaluation of prognostic factors on survival in Iranian colorectal cancer patients: a competing risks survival analysis. Asian Pac J Cancer Prev 2009; 10: 815-821.
46. Baade PD, Meng X, Youl PH, Aitken JF, Dunn J, Chambers SK. The impact of body mass index and physical activity on mortality among patients with colorectal cancer in Queensland, Australia. Cancer Epidemiol Biomarkers Prev 2011; 20: 1410-1420.
47. Ballian N, Yamane B, Leverson G etal. Body mass index does not affect postoperative morbidity and oncologic outcomes of total mesorectal excision for rectal adenocarcinoma. Ann Surg Oncol 2010; 17: 1606-1613.
48. Chern H, Chou J, Donkor C etal. Effects of obesity in rectal cancer surgery. J Am Coll Surg 2010; 211: 55-60.
49. Chin CC, Kuo YH, Yeh CY etal. Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol 2012; 18: 4191-4198.
50. Healy LA, Ryan AM, Sutton E etal. Impact of obesity on surgical and oncological outcomes in the management of colorectal cancer. Int J Colorectal Dis 2010; 25: 1293-1299.
51. Hines RB, Shanmugam C, Waterbor JW etal. Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer. Cancer 2009; 115: 5798-5806.
52. Min YW, Kim SA, Lee JH etal. Overweight is associated with a favorable survival in patients with colorectal cancer: a prospective cohort study in an Asian population. Ann Surg Oncol 2012; 19: 3460-3464.
53. Moon HG, Ju YT, Jeong CY etal. Visceral obesity may affect oncologic outcome in patients with colorectal cancer. Ann Surg Oncol 2008; 15: 1918-1922.
54. Rickles AS, Iannuzzi JC, Mironov O etal. Visceral obesity and colorectal cancer: are we missing the boat with BMI? J Gastrointest Surg 2013; 17: 133-143.
55. Volkova E, Willis JA, Wells JE, Robinson BA, Dachs GU, Currie MJ. Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer 2011; 104: 51-59.
56. Yamamoto N, Fujii S, Sato T etal. Impact of body mass index and visceral adiposity on outcomes in colorectal cancer. Asia Pac J Clin Oncol 2012; 8: 337-345.
57. Dignam JJ, Polite BN, Yothers G etal. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. J Natl Cancer Inst 2006; 98: 1647-1654.
58. Meyerhardt JA, Catalano PJ, Haller DG etal. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Cancer 2003; 98: 484-495.
59. Meyerhardt JA, Niedzwiecki D, Hollis D etal. Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803. J Clin Oncol 2008; 26: 4109-4115.
60. Meyerhardt JA, Tepper JE, Niedzwiecki D etal. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 2004; 22: 648-657.
61. Sinicrope FA, Foster NR, Sargent DJ, O'Connell MJ, Rankin C. Obesity is an independent prognostic variable in colon cancer survivors. Clin Cancer Res 2010; 16: 1884-1893.
62. Guiu B, Petit JM, Bonnetain F etal. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 2010; 59: 341-347.
63. Pathak S, Tang JM, Terlizzo M, Poston GJ, Malik HZ. Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases. Eur J Surg Oncol 2010; 36: 52-57.
64. Simkens LH, Koopman M, Mol L etal. Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapy. Eur J Cancer 2011; 47: 2560-2567.
65. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012; 99: 550-557.
66. Renehan AG, Crosbie EJ, Campbell PT. Pre- and post-diagnosis BMI, and the Will Rogers phenomenon [letter to editor - accepted]. J Natl Cancer Inst 2013; DOI: 10.1093/jnci/djt375.
67. Sinicrope FA, Foster NR, Yothers G etal. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy. Cancer 2013; 119: 1528-1536.
68. Parkin E, Plumb AA, O'Reilly D, Renehan AG. Body composition and outcome in patients undergoing resection of colorectal liver metastases (Br J Surg 2012; 99: 550-557). Br J Surg 2012; 99: 1021-1022, author reply 1022.
69. Vrieling A, Kampman E. The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 2010; 92: 471-490.
70. Whitlock G, Lewington S, Sherliker P etal. Body-mass index and cause-specific mortality in 9, 00, 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-1096.
71. Chambers P, Daniels SH, Thompson LC, Stephens RJ. Chemotherapy dose reductions in obese patients with colorectal cancer. Ann Oncol 2012; 23: 748-753.
72. Prado CM, Lieffers JR, McCargar LJ etal. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 2008; 9: 629-635.
73. Yun KE, Chang Y, Jung HS etal. Impact of body mass index on the risk of colorectal adenoma in a metabolically healthy population. Cancer Res 2013; 73: 4020-4027.
74. Renehan AG, Flood A, Adams KF etal. Body mass index at different adult ages, weight change, and colorectal cancer risk in the national institutes of health-AARP cohort. Am J Epidemiol 2012; 176: 1130-1140.